A case of subcutaneous plasmacytomas of vessel puncture site in multiple myeloma after autologous stem cell transplantation.
- Author:
Jung Hyun KWON
1
;
Seung Hwan LEE
;
Ji Hyun KIM
;
Eun Mi HWANG
;
Chong Won PARK
Author Information
1. Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea. cwp@cmc.cuk.ac.kr
- Publication Type:Case Report
- Keywords:
Multiple myeloma;
Subcutaneous Plasmacytomas;
Autologous stem cell transplantation
- MeSH:
Catheters;
Cisplatin;
Cytarabine;
Drug Therapy;
Etoposide;
Hematopoietic Stem Cell Transplantation;
Humans;
Methylprednisolone Hemisuccinate;
Middle Aged;
Multiple Myeloma*;
Plasmacytoma*;
Punctures*;
Stem Cell Transplantation*;
Stem Cells*;
Tropism
- From:Korean Journal of Medicine
2004;67(1):83-88
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
We report a case of a 61-year-old man with Durie-Salmon stage IB, kappa light chain type, multiple myeloma (MM), who relapsed 6 months after autologous hematopoietic stem cell transplantation (HSCT). One month after vinblastin-mitoxantrone-dexamethasone chemotherapy, he presented with multiple subcutaneous plasmacytomas. These lesions were confined to previous vessel puncture sites such as subclavian central catheter insertion site, anchoring site and sampling site. He had no past history of plasmacytoma. After additional treatment of etoposide, cisplatin, solumedrol, cytosine arabinoside, the plasmacytomas decreased or disappeared. But blasts reappeared in his peripheral blood and the size of the plasmacytomas increased. This case represents the rare report of refractory MM presenting as multiple subcutaneous plasmacytomas with specific tropism to the sites of previous trauma.
